Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
about
The Clinical Inadequacy of the Placebo Model and the Development of an Alternative Conceptual Framework.Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.What psychologists need to know about psychotropic medications.Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
P2860
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@en
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@nl
type
label
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@en
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@nl
prefLabel
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@en
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@nl
P2093
P2860
P356
P1476
Antipsychotic-Induced Dopamine ...... cology, Criteria, and Therapy.
@en
P2093
Anne-Noël Samaha
Charles-Siegfried Peretti
Guy Chouinard
Masaomi Iyo
Masayuki Takase
Nobuhisa Kanahara
Virginie-Anne Chouinard
P2860
P304
P356
10.1159/000477313
P577
2017-06-24T00:00:00Z